Headlines

Less Than One Hour Before The NASDAQ Open, Sypris Solutions Is Down By 6%

(VIANEWS) – The NASDAQ opens in less than one hour and Sypris Solutions‘s pre-market value is already 6.36% down. Sypris Solutions’s last close was $2.20, 4.35% below its 52-week high of $2.30. The last session, NASDAQ finished with Sypris Solutions (SYPR) rising 1.38% to $2.20. NASDAQ jumped 0.32% to $15,360.29, after three successive sessions in…

Read More

Less Than Two Hours Before The NASDAQ Open, Inovio Pharmaceuticals Is Down By 20%

(VIANEWS) – The NASDAQ opens in less than two hours and Inovio Pharmaceuticals‘s pre-market value is already 20.5% down. Inovio Pharmaceuticals’s last close was $0.69, 64.52% under its 52-week high of $1.95. The last session, NASDAQ ended with Inovio Pharmaceuticals (INO) rising 2.56% to $0.69. NASDAQ jumped 0.32% to $15,360.29, after three sequential sessions in…

Read More

LendingTree Stock Bullish Momentum With A 10.12% Rise Today

(VIANEWS) – The NASDAQ ended the session with LendingTree (TREE) jumping 10.12% to $30.46 on Monday while NASDAQ rose 0.32% to $15,360.29. LendingTree’s last close was $27.66, 42.16% below its 52-week high of $47.82. About LendingTree LendingTree, Inc., through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates…

Read More

Pacific Biosciences Stock Plummets 32% In 21 Sessions: What’s Driving The Decline?

(VIANEWS) – Pacific Biosciences of California (NASDAQ: PACB) shares have fallen by 32.87% over 21 sessions, from EUR10.16 on December 19th to EUR6.82 at 12:41 EST on Monday morning despite two consecutive gains on Thursday and Friday; even as the NASDAQ index increased 0.33% to EUR15,360.97 during that same time frame – Pacific Biosciences’ last…

Read More

FibroGen Soars As Positive Trial Results Boost Optimism

(VIANEWS) – About FibroGen Yearly Analysis Technical Analysis Quarter Analysis Sales Growth desfasoarante FibroGen’s sales growth has been staggering with an impressive 5.3% rise during this quarter and even greater 16.4% expansion scheduled for next. Growth Estimates QuartersAccording to current estimates, the company is projected to experience quarterly growth estimates of 37.1% and 46.9% in…

Read More